Article
Recommendations for Clinical CYP2D6 Genotyping Allele Selection: A Joint Consensus Recommendation of the Association for Molecular Pathology, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, and the European Society for Pharmacogenomics and Personalized Therapy.
The Journal of molecular diagnostics : JMD - 1 Sept 2021
Pratt Victoria M, Cavallari Larisa H, Del Tredici Andria L, Gaedigk Andrea, Hachad Houda, Ji Yuan, Kalman Lisa V, Ly Reynold C, Moyer Ann M, Scott Stuart A, van Schaik R H N, Whirl-Carrillo Michelle, Weck Karen E
Abstract excerpt
The goals of the Association for Molecular Pathology Clinical Practice Committee's Pharmacogenomics (PGx) Working Group are to define the key attributes of pharmacogenetic alleles recommended for clinical testing, and to determine a minimal set of variants that should be included in clinical PGx genotyping assays. This document series provides recommendations on a minimal panel of variant alleles (Tier 1) and an...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.